Abstract Coronavirus disease-2019 (COVID-19) is primarily a respiratory disease, however,
an increasing number of reports indicate that SARS-CoV-2 infection can also cause severe …

Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection in humans. Despite several emerging vaccines, there …

The current COVID-19 pandemic is caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). We demonstrate that despite the large size of the viral RNA …

Introduction Effective cell-based production processes of virus particles are the foundation
for the global availability of classical vaccines, gene therapeutic vectors, and viral oncolytic …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has infected more than
160 million people and resulted in more than 3.3 million deaths, and despite the availability …

A recent study proposed that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) hijacks the LINE-1 (L1) retrotransposition machinery to integrate into the DNA of infected …

SARS-CoV-2 (CoV-2) viral infection results in COVID-19 disease, which has caused
significant morbidity and mortality worldwide. A vaccine is crucial to curtail the spread of …

Aging is a major risk factor for neurodegenerative diseases, and coronavirus disease 2019
(COVID-19) is linked to severe neurological manifestations. Senescent cells contribute to …

Objectives Efforts to develop and deploy effective vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS‐CoV‐2) continue at pace. Here, we describe rational …

Herein, we report the synthesis and biological evaluation of a novel series of heparinoid
amphiphiles as inhibitors of heparanase and SARS-CoV-2. By employing a tailor-made …